Simone
Senior Member (Voting Rights)
Dr Zack Shan (who has been working with the NCNED group at Griffith University, and is now based at University of Sunshine Coast) has been awarded a $1.2m grant to undertake an ME/CFS neuroimaging project. This is an NHMRC grant (NHMRC is the equivalent of NIH here in Australia), and it’s the first time in more than 10 years that a biomedical ME/CFS project has been successful in NHMRC’s competitive grants project.
In total, there were 2651 applications for these grants and just 294 were funded (11%). (I’m not sure how that compares with NIH or MRC?)
PROJECT:
Title: “Multimodal MRI of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Understanding its Neuropathophysiology and Developing an Objective Neuromarker”
Grant: $1,269,545.70
Description: “This translational brain imaging study will investigate the underlying brain disease process of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and develop a multimodal imaging diagnostic marker for it. Understanding the brain disease process of ME/CFS will allow design of biologically based therapeutic interventions. A diagnostic marker for ME/CFS will alleviate the distressing diagnostic odyssey currently experienced by the patients and facilitate multicentre clinical trials.”
https://www.nhmrc.gov.au/funding/data-research/outcomes-funding-rounds
This grant is in addition to the health economics study and $3m Targeted Call for a Research which the government has also funded.
In total, there were 2651 applications for these grants and just 294 were funded (11%). (I’m not sure how that compares with NIH or MRC?)
PROJECT:
Title: “Multimodal MRI of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Understanding its Neuropathophysiology and Developing an Objective Neuromarker”
Grant: $1,269,545.70
Description: “This translational brain imaging study will investigate the underlying brain disease process of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and develop a multimodal imaging diagnostic marker for it. Understanding the brain disease process of ME/CFS will allow design of biologically based therapeutic interventions. A diagnostic marker for ME/CFS will alleviate the distressing diagnostic odyssey currently experienced by the patients and facilitate multicentre clinical trials.”
https://www.nhmrc.gov.au/funding/data-research/outcomes-funding-rounds
This grant is in addition to the health economics study and $3m Targeted Call for a Research which the government has also funded.